Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of NRX Pharmaceuticals Inc (NASDAQ: NRXP) was $2.07 for the day, down -5.91% from the previous closing price of $2.2. In other words, the price has decreased by -$5.91 from its previous closing price. On the day, 0.59 million shares were traded. NRXP stock price reached its highest trading level at $2.2378 during the session, while it also had its lowest trading level at $2.06.
Ratios:
Our analysis of NRXP’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.29 and its Current Ratio is at 0.29.
Upgrades & Downgrades
In the most recent recommendation for this company, H.C. Wainwright on September 08, 2025, initiated with a Buy rating and assigned the stock a target price of $40.
On April 02, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $18.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 17 ’24 when Javitt Jonathan C bought 40,000 shares for $1.17 per share. The transaction valued at 46,800 led to the insider holds 84,634 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NRXP now has a Market Capitalization of 58162088 and an Enterprise Value of 61234088. For the stock, the TTM Price-to-Sale (P/S) ratio is 242.33. Its current Enterprise Value per Revenue stands at 253.033 whereas that against EBITDA is -4.029.
Stock Price History:
The Beta on a monthly basis for NRXP is 1.64, which has changed by 0.8333334 over the last 52 weeks, in comparison to a change of 0.13613915 over the same period for the S&P500. Over the past 52 weeks, NRXP has reached a high of $6.01, while it has fallen to a 52-week low of $1.17. The 50-Day Moving Average of the stock is -24.15%, while the 200-Day Moving Average is calculated to be -21.62%.
Shares Statistics:
NRXP traded an average of 446.89K shares per day over the past three months and 449810 shares per day over the past ten days. A total of 27.68M shares are outstanding, with a floating share count of 24.85M. Insiders hold about 11.55% of the company’s shares, while institutions hold 24.76% stake in the company. Shares short for NRXP as of 1764288000 were 1262366 with a Short Ratio of 2.82, compared to 1761868800 on 860796. Therefore, it implies a Short% of Shares Outstanding of 1262366 and a Short% of Float of 4.8.
Earnings Estimates
A comprehensive evaluation of NRX Pharmaceuticals Inc (NRXP) is underway, with the input of 1.0 analysts contributing to its current rating.The consensus estimate for the next quarter is $0.09, with high estimates of $0.09 and low estimates of $0.09.
Analysts are recommending an EPS of between -$1.33 and -$1.33 for the fiscal current year, implying an average EPS of -$1.33. EPS for the following year is $0.25, with 1.0 analysts recommending between $0.25 and $0.25.
Revenue Estimates
For the next quarter, 4 analysts are estimating revenue of $23.75M. There is a high estimate of $25M for the next quarter, whereas the lowest estimate is $22.5M.
Based on 4 analysts’ estimates, the company’s revenue will be $126.84M in the next fiscal year. The high estimate is $241.4M and the low estimate is $42.57M.
